Concepedia

Nicholas R. Perl

NR

13

Publications

450

Citations

13

H-Index

2005

Active since

Affiliations

Columbia University(Current)

Ribon Therapeutics (United States)

Memorial Sloan Kettering Cancer Center

Ironwood Pharmaceuticals (United States)

Nicholas R. Perl is an author at Columbia University specializing in organic chemistry, chemistry, and natural sciences.

ORCID

Top concepts

Publications per year

2005–2023

13

Publications

13

Design and Synthesis of Potent <i>Quillaja</i> Saponin Vaccine Adjuvants

Michelle M. Adams, Payal Damani, Nicholas R. Perl et al. · Journal of the American Chemical Society · 2010 · 84 citations

, , +13

Annulation of Thioimidates and Vinyl Carbodiimides to Prepare 2-Aminopyrimidines, Competent Nucleophiles for Intramolecular Alkyne Hydroamination. Synthesis of (−)-Crambidine

Nicholas R. Perl, Nathan D. Ide, Sudeep Prajapati et al. · Journal of the American Chemical Society · 2010 · 62 citations

Allylsilane–Vinylarene Cross‐Metathesis Enables a Powerful Approach to Enantioselective Imine Allylation

John D. Huber, Nicholas R. Perl, James L. Leighton · Angewandte Chemie International Edition · 2008 · 42 citations

Enantioselective Imidazole-Directed Allylation of Aldimines and Ketimines

Nicholas R. Perl, James L. Leighton · Organic Letters · 2007 · 40 citations

, , +10

PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models

Chun Wai Wong, Christos Evangelou, Kieran N. Sefton et al. · Nature Communications · 2023 · 34 citations · Full text

Rows per page

1–5 of 13